Legend Biotech (LEGN) Non-Current Assets (2019 - 2026)

Legend Biotech (LEGN) has 8 years of Non-Current Assets data on file, last reported at $514.0 million in Q1 2026.

• Quarterly Non-Current Assets rose 29.52% year-over-year to $514.0 million in Q1 2026, while the trailing twelve-month figure through Dec 2025 was $486.6 million (up 25.96% YoY) and the FY2025 annual result came in at $486.6 million, up 25.96% from the prior year.
• Non-Current Assets rose to $514.0 million in Q1 2026, from $486.6 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $514.0 million in Q1 2026 to a low of $179.8 million in Q1 2022.
• A 5-year average of $368.0 million and a median of $373.4 million in 2024 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2022 — Non-Current Assets jumped 128148.17% — and 2025, when it advanced 9.84%.
• Tracing LEGN's Non-Current Assets over 5 years: stood at $231.8 million in 2022, then surged by 51.31% to $350.8 million in 2023, then gained by 10.12% to $386.3 million in 2024, then climbed by 25.96% to $486.6 million in 2025, then gained by 5.63% to $514.0 million in 2026.
• The last three Non-Current Assets figures came in at $514.0 million (Q1 2026), $486.6 million (Q4 2025), and $470.9 million (Q3 2025), per Business Quant data.